RNA-based cancer vaccines: mechanisms, clinical progress, and translational challenges

Aya Y Al-Kabariti1, Munthar Abosaoda Kadhim2,3, Hayjaa Mohaisen Mousa4

  • 1Faculty of Pharmacy, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.

Immunologic Research
|November 20, 2025
PubMed

Insights

RNA vaccines, including mRNA, offer a promising new approach for cancer treatment and prevention. These advanced vaccines induce strong immune responses and show potential for scalable manufacturing and safety in patients.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • RNA-based vaccines (mRNA, circular RNA, self-amplifying mRNA) represent a significant advancement in vaccine technology.
  • These platforms are being explored for their potential in tumor prevention and treatment.
  • RNA vaccines offer advantages over conventional antitumor vaccines like peptide and DNA vaccines.

Purpose of the Study:

  • To review the types, advances, and applications of RNA vaccines in antitumor therapy.
  • To discuss the challenges associated with RNA vaccine development and use.
  • To explore future technological directions for enhancing RNA vaccine platforms.

Main Methods:

  • This review synthesizes information from preclinical and clinical investigations.
  • It analyzes the characteristics and potential of various RNA vaccine modalities.
  • The review examines the application of RNA vaccines across diverse tumor types.

Main Results:

  • RNA vaccines demonstrate the capacity to encode multiple antigens and elicit robust immune responses.
  • Preliminary studies show encouraging outcomes for RNA vaccines in various cancer types.
  • RNA vaccines offer potential for rapid development, scalable manufacturing, and acceptable safety profiles.

Conclusions:

  • RNA vaccines are a promising platform for cancer immunotherapy, offering unique advantages.
  • Further technological development is needed to overcome current challenges and optimize efficacy.
  • RNA vaccine technology holds significant potential for broad therapeutic applications in oncology.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K